Prophylactic antibiotics in cesarean section: a double-blind study.
D000328:Adult; D000367:Age Factors; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000517:prevention & control*; D002585:Cesarean Section; D002986:Clinical Trials as Topic; D004716:Endometritis / Q000453:epidemiology; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D007743:Labor, Obstetric; D007902:Length of Stay; D008712:Methicillin / Q000627:therapeutic use; D010919:Placebos; D011014:Pneumonia / Q000453:epidemiology; D011183:Postoperative Complications / Q000517:prevention & control*; D011247:Pregnancy; D001261:Pulmonary Atelectasis / Q000453:epidemiology; D014552:Urinary Tract Infections / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D010919:Placebos; D007612:Kanamycin; D000667:Ampicillin; D008712:Methicillin